Search clinical trials for: Enalapril+Maleate

Total 1024 results

ACO Hud Nordic AB

Completed

Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser

Atopic Eczema

Sweden
ACO Hud Nordic AB
Smerud Medical Research International AS

Completed

A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema

Hand Eczema

Norway
Stamford Hospital

Withdrawn

Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

Overactive Bladder | Urge Incontinence | Urinary Urge

United States
Massachusetts General Hospital

Recruiting

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

Hemangioma

United States
Merck Sharp & Dohme LLC

Completed

Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) (DISCOVER)

Ocular Hypertension | Open Angle Glaucoma
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer

Breast Cancer

United States
Medtronic Xomed, Inc.
Medtronic

Terminated

Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea (Pillar-CPAP)

Obstructive Sleep Apnea (OSA)

United States
Association pour la Recherche Clinique et Immunologique

Unknown

Dupilumab Impact on Skin Resident Memory T Cells (DupiTrem)

Atopic Dermatitis

France
Santen Inc.

Completed

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

Glaucoma and Ocular Hypertension

United States
Novartis Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

COPD

Germany, Belgium, Poland, Romania, Italy, Spain, Estonia, Russian Federation, Austria, France, Slovakia, Czechia, Latvia, Lithuania, Greece, Hungary, United Kingdom, Portugal, Ireland, Norway, Slovenia, Denmark, Sweden
Merck Sharp & Dohme LLC

Completed

Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)

Ocular Hypertension | Glaucoma
Alcon Research

Completed

Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy

Glaucoma

Germany
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

Ocular Hypertension | Glaucoma
Taipei Medical University WanFang Hospital

Completed

The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study

Paronychia | Epidermal Growth Factor Receptor Inhibitor

Taiwan
Novartis Pharmaceuticals

Completed

Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) (POWER)

Chronic Obstructive Pulmonary Disease

Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

Gastric Ulcer

Korea, Republic of
National Cancer Institute (NCI)

Terminated

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
Ajeet Gajra
Merck Sharp & Dohme LLC

Unknown

Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy

Nausea | Vomiting | Non-small Cell Lung Cancer | Emesis

United States
Alcon Research

Completed

Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

Ocular Hypertension | Glaucoma | Open-angle Glaucoma
University of Glasgow

Completed

Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery

Cervical Cancer

United Kingdom
Shanghai Chest Hospital

Not yet recruiting

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

NRG1-fused Non-small Cell Lung Cancer

China
Brigham and Women's Hospital

Completed

Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period

Hypertension in Pregnancy | Postpartum | Postpartum Preeclampsia | Gestational Hypertension | Preeclampsia Severe

United States
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
Shengjing Hospital

Recruiting

Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients

Breast Neoplasms

China
NCIC Clinical Trials Group

Completed

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Colorectal Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Canada
University of Florida

Completed

Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses

Glaucoma

United States
Alcon Research

Completed

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America

Glaucoma
Alcon Research

Terminated

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil

Glaucoma

Brazil
US Department of Veterans Affairs
Icahn School of Medicine at Mount Sinai; Alzheimer's Association

Completed

Randomized Trial of a Nutritional Supplement in Alzheimer's Disease

Alzheimer's Disease

United States
Janssen-Ortho LLC
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine

Migraine | Common Migraine | Classic Migraine
BiliCam, LLC
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

BiliCam Clinical Validation Study

Newborn Jaundice

United States
National Cancer Institute (NCI)
AstraZeneca

Active, not recruiting

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Metastatic Lung Non-Small Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Advanced Malignant Solid Neoplasm | Unresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Stage IIIA Lung Non-Small... and other conditions

United States, Canada
LEO Pharma

Completed

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis

Psoriasis Vulgaris

Germany
University of Rochester

Not yet recruiting

Reducing Frailty for Older Cancer Survivors Using Supplements II (ReFOCUS2)

Inflammation | Frailty

United States
Baylor College of Medicine
National Center for Complementary and Integrative Health (NCCIH)

Completed

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

HIV Infection

United States
GlaxoSmithKline

Completed

Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis

Psoriasis

Germany
Hamilton Health Sciences Corporation

Completed

Blood Pressure Management in Stroke Following Endovascular Treatment (DETECT)

Blood Pressure | Stroke, Acute | Mechanical Thrombectomy | Endovascular Thrombectomy | Vessels; Occlusion

Canada
Göteborg University
Sahlgrenska University Hospital, Sweden

Completed

Expression and Function of the Renin-Angiotensin System in the Esophagus

Barrett's Esophagus

Sweden
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

Advanced Solid Tumors

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Kidney Cancer | Metastatic Cancer | Melanoma (Skin)

United States
Institut Claudius Regaud

Completed

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Kidney Cancer | Metastatic Cancer

France
National Cancer Institute (NCI)

Terminated

Sunitinib in Treating Patients With Idiopathic Myelofibrosis

Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia... and other conditions

United States
National Eye Institute (NEI)

Terminated

Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome (VHL3)

Von Hippel-Lindau Syndrome

United States
UNICANCER

Completed

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Kidney Cancer

France
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Kidney Cancer

United States
Johannes Gutenberg University Mainz
Pfizer

Completed

Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer

Gastric Adenocarcinoma | Barrett Esophagus

Germany
Shengjing Hospital

Recruiting

Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC

Breast Cancer

China
Santen Pharmaceutical (Taiwan) Co., LTD

Completed

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting

Primary Open Angle Glaucoma | Ocular Surface Disease

Taiwan
Stanford University

Withdrawn

The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.

Ocular Hypertension | Glaucoma | Thyroid Eye Disease

United States

Search clinical trials for: Enalapril+Maleate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations